Table: begin end state 1 25 cytoplasmic 26 49 transmembrane 50 54 non-cytoplasmic 55 74 transmembrane 75 94 cytoplasmic 95 116 transmembrane 117 121 non-cytoplasmic 122 144 transmembrane 145 162 cytoplasmic 163 183 transmembrane 184 194 non-cytoplasmic 195 218 transmembrane 219 245 cytoplasmic 246 269 transmembrane 270 278 non-cytoplasmic 279 298 transmembrane 299 309 cytoplasmic 310 329 transmembrane 330 335 non-cytoplasmic 336 360 transmembrane 361 379 cytoplasmic 380 405 transmembrane 406 416 non-cytoplasmic 417 443 transmembrane 444 466 cytoplasmic
Input: >N515DRAFT_2416 FitnessBrowser__Dyella79:N515DRAFT_2416 MTIALESSPARAAAMADRLTLREKVGYGLGDAGGNVVIVLAMNFLNFFYTDVYGISPATV GLMFLAVRIFDAFADPVMGILADHTRSRWGRYRPWQLWVALPLGVAVVLAFTVPPLQGDA RIAWACVTYLLLSLGYTAINVPYCAMINAMTVSRREVVSCQSWRFALCGAAALLVSTALP WLVEQWSGAGGPARGYQRGAAAMCAVAAAMFLCCFLWVRERVPLRNEAFSLRRLADGLRR NDQLQLMLVMSFLLITILNVRGGGYLYFITYVLRGDARYASLFFGAVALAAILGALLVGP LSRWLDTVRFYRYVNLALAAVSASMWFIPGGADAQLAWLLAMFGSGVVLGLCLPLHFSVM AFADDYGQWKTGVRSSGMNFAFNLVFIKLAWASGAGIIALVLYLVRYQAGVAQTVTALGG ITAIQTLIPAAIHLLLAFTLGFCRLDDATMKRVSQDLQQRHTDRPG
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server